The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis

Tatsuki Uchiyama(Kyoto University), Akifumi Takaori‐Kondo(Kyoto University)

Cancer Medicine

August 15, 2015

10.1002/cam4.502

Cited by 27

Related Papers

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

|Nature|2022|1.2k

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

|Nature|2021|680

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

|Nature Medicine|2020|633

Germ line<i>DDX41</i>mutations define a unique subtype of myeloid neoplasms

|Blood|2022|142

SARS-CoV-2 Omicron spike mediated immune escape and tropism shift

|bioRxiv (Cold Spring Harbor Laboratory)|2021|64